These 34 patients were generally young at primary diagnosis (52% were younger than 50 years old) and had a primary BC and LM, which were ER+/HER2non-amp in 87.5% (21/4) and 67% (22/33) of the patients. The gene discussed is ESR1; the disease is breast cancer.